Duncan Williams Asset Management’s AbbVie ABBV Stock Holding History

Duncan Williams Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	5,016 +23	+0.5%	+$4.95K	0.28%	55
2026 Q1	$1.09M	Sell	4,993 -23	-0.5%	-$5.1K	0.3%	48
2025 Q4	$1.09M	Sell	5,016 -124	-2%	-$28.2K	0.27%	52
2025 Q3	$1.19M	Buy	5,140 +160	+3%	+$32.6K	0.33%	47
2025 Q2	$924K	Buy	4,980 +47	+1%	+$8.73K	0.29%	56
2025 Q1	$1.03M	Buy	4,933 +73	+2%	+$14.2K	0.37%	50
2024 Q4	$864K	Buy	4,860 +600	+14%	+$110K	0.34%	52
2024 Q3	$841K	Buy	4,260 +2,454	+136%	+$458K	0.46%	40
2024 Q2	$310K	Buy	1,806 +21	+1%	+$3.48K	0.26%	55
2024 Q1	$325K	Buy	+1,785	New	+$308K	0.29%	55

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Duncan Williams Asset Management's ABBV Position: Q2 2026 in Review

Duncan Williams Asset Management increased its AbbVie (ABBV) stake by 0.46% in Q2 2026, buying an estimated $4.95K and bringing the position to 5,016 shares worth $1.26M. The position accounts for 0.28% of the portfolio, ranked #55.

Duncan Williams Asset Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Duncan Williams Asset Management held 5,016 shares of AbbVie worth $1.26M as of Q2 2026.
Duncan Williams Asset Management bought 23 AbbVie shares in Q2 2026, an estimated $4.95K.
AbbVie made up 0.28% of Duncan Williams Asset Management's portfolio in Q2 2026, its #55 holding.
Duncan Williams Asset Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Duncan Williams Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.